Trends in pulmonary arterial hypertension: insights from Global Burden of Disease 1990–2021
While global age-standardised rates have declined, PAH remains a significant global health burden, particularly in low-SDI regions. These findings underscore the need for targeted prevention and intervention strategies, especially for high-risk populations, such as females and the elderly, to reduce the global health impact of PAH.
Authors
- Hanxiong Liu (ORCID: https://orcid.org/0000-0001-6559-9446)
- Xu Wu (ORCID: https://orcid.org/0000-0002-0436-5969)
- Li Sun (ORCID: https://orcid.org/0000-0003-2006-3124)
- Yi Zheng (ORCID: https://orcid.org/0000-0002-2161-5480)
- Yuebin Wang (ORCID: https://orcid.org/0000-0002-6978-4558)
- Xian Su (ORCID: https://orcid.org/0000-0002-5120-2775)
- Shuwei Suo
Institutions
- Third People's Hospital of Chengdu (CN)
- Southwest Jiaotong University (CN)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-095348
- Citations
- 5
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 7.59
Funders
- Bill and Melinda Gates Foundation
- Institute for Health Metrics and Evaluation